Evolent Health Bundle

How Does Evolent Health Company Work?
Evolent Health is a key player in healthcare technology and services, focusing on value-based care. In 2024, the company achieved a substantial revenue of $2.55 billion, a 30.1% increase year-over-year. This growth highlights its expanding influence and the rising demand for its specialized solutions.

The company's technology-enabled services help clients manage population health and optimize value-based care. With around 40 million members covered by its solutions and a workforce of 4,500 professionals, Evolent Health is instrumental in improving patient outcomes and reducing costs.
Evolent Health's operational model centers on providing integrated technology and services to health plans and providers. This approach facilitates the transition to value-based care by improving care coordination, managing risk, and enhancing administrative efficiency. Their platform supports a range of functions, from member engagement to clinical decision support, all aimed at achieving better health outcomes at a lower cost. This comprehensive strategy is further detailed in the Evolent Health PESTEL Analysis, offering insight into the external factors influencing its operations.
What Are the Key Operations Driving Evolent Health’s Success?
The Evolent Health business model centers on partnering with health plans and providers to facilitate the shift to value-based care. They offer technology-enabled services and solutions designed to enhance clinical outcomes, patient experiences, and reduce overall healthcare expenditures. This approach is fundamental to understanding how Evolent Health works.
Evolent Health’s operations involve managing populations by leveraging advanced data analytics and proprietary technology. This includes identifying at-risk patients and coordinating their care to improve health outcomes.
The company's core value proposition is to enable and accelerate the transition to value-based care. They achieve this by focusing on improving clinical results, enhancing patient satisfaction, and lowering healthcare costs for their partners.
Key Evolent Health solutions encompass care management and coordination, alongside administrative simplification. These services are crucial for partners seeking to optimize their healthcare delivery models.
Evolent Health partners with a national network of leading payers, including managed Medicaid and Medicare Advantage plans, as well as provider organizations like hospitals and physician groups.
The company utilizes advanced data analytics and its proprietary Identifi® platform to manage care effectively. This technology supports data aggregation, care workflows, and patient engagement, which are central to how Evolent Health works.
- The Identifi® platform facilitates proactive care management.
- It enables robust risk adjustment services.
- The platform drives performance improvement initiatives.
- It supports specialized solutions across various medical fields.
Evolent Health's operational approach is deeply integrated, often involving embedding teams within client organizations to provide direct clinical and administrative support. This hands-on involvement, combined with a partnership model that shares risk and rewards, aligns incentives to achieve superior health outcomes and financial performance. This integrated approach, which combines sophisticated technology with deep clinical and operational expertise, is a key differentiator for Evolent Health, allowing them to deliver end-to-end solutions that yield measurable financial and clinical results for their partners. Understanding the Growth Strategy of Evolent Health further illuminates their operational framework.
Evolent Health SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format

How Does Evolent Health Make Money?
Evolent Health generates revenue through a diverse portfolio of technology-enabled services and solutions, balancing capitation-based and fee-based models. The company's primary revenue streams are derived from its Performance Suite and Technology & Service Suite, reflecting its comprehensive approach to healthcare management.
The Performance Suite, which includes capitation-based solutions, represented the largest revenue contributor for Evolent Health. In Q2 2025, this segment generated $267.92 million, accounting for approximately 60.3% of the total revenue.
Evolent Health's Technology & Service Suite, comprising fee-based offerings, is another significant revenue driver. For Q2 2025, this suite brought in $81.40 million, making up about 18.3% of the company's total revenue.
Administrative Services contribute to the company's revenue, making up 12.6% of the total in Q2 2025. This segment supports the operational efficiency of healthcare providers and payers.
Key monetization strategies include subscription fees for access to Evolent's technology platform and services. The company also utilizes per-member-per-month (PMPM) fees for specific services offered to clients.
Evolent Health also earns revenue through performance-based incentives, receiving bonuses for improvements achieved by its clients. This aligns the company's financial success with client outcomes.
Consulting services for implementing value-based care strategies are another revenue stream. Additionally, the company engages in shared savings agreements, further aligning its financial interests with those of its partners.
For the full year ended December 31, 2024, Evolent Health reported total revenue of $2.55 billion. The company anticipates full-year revenue for 2025 to be in the range of approximately $2.06 billion to $2.11 billion, reflecting adjustments for contract changes. Despite shifts in revenue mix, such as an increase in Medicaid revenue to 43.4% and a decrease in Medicare revenue to 24.5% in Q2 2025, Evolent Health remains focused on expanding its client base and service offerings to ensure sustained revenue growth. Understanding the Marketing Strategy of Evolent Health provides further insight into how these revenue streams are cultivated and managed.
Evolent Health's financial performance is characterized by substantial revenue generation and a strategic focus on value-based care. The company's operational model is designed to manage healthcare costs and improve patient outcomes through integrated solutions.
- Total Revenue (FY 2024): $2.55 billion
- Q2 2025 Total Revenue: $444.3 million
- Q2 2025 Performance Suite Revenue: $267.92 million (60.3%)
- Q2 2025 Technology & Service Suite Revenue: $81.40 million (18.3%)
- Q2 2025 Administrative Services Revenue: 12.6%
- Anticipated FY 2025 Revenue: $2.06 billion - $2.11 billion
- Q2 2025 Medicaid Revenue: 43.4%
- Q2 2025 Medicare Revenue: 24.5%
Evolent Health PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable

Which Strategic Decisions Have Shaped Evolent Health’s Business Model?
Evolent Health has navigated significant strategic shifts and achieved key milestones, notably renegotiating Performance Suite contracts to yield an estimated $115 million annual improvement in net income and adjusted EBITDA for 2025. These moves address past operational challenges, particularly elevated oncology costs that impacted 2024 performance.
The company has secured new revenue agreements, including two significant deals in Q4 2024 and multiple agreements in Q1 and Q2 2025. These are projected to contribute $250 million in annual revenue once fully operational.
New agreements include a major health plan in New England for Evolent Technology and Services, impacting 1.9 million members in 2025. Services are also expanding into cardiology, musculoskeletal, and advanced imaging areas.
A notable contract with Aetna for its oncology Performance Suite is set to commence in Q1 2026. This agreement will cover approximately 250,000 Medicare Advantage lives in Florida, demonstrating a focused approach to specialized care management.
Evolent Health is investing approximately $35 million in capitalized software development for 2025, including AI-based automation initiatives like Auth Intel. This investment aims to enhance cost efficiencies and operational performance.
Evolent Health's competitive advantage stems from its comprehensive value-based care solutions, robust relationships with major health systems, and deep clinical expertise. The proprietary Identifi® platform and its integrated approach underscore its technological leadership in the market.
- Driving tangible financial and clinical outcomes for partners.
- Maintaining a consistent revenue growth trajectory, with 30.1% growth in 2024.
- Adapting to industry trends through investments in AI and automation.
- Providing advanced Evolent Health technology solutions for payers.
- Understanding Evolent Health's role in healthcare through its integrated care solutions.
Evolent Health Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout

How Is Evolent Health Positioning Itself for Continued Success?
Evolent Health operates as a significant player in the healthcare technology and services sector, focusing on value-based care and population health management. The company assists organizations in transitioning from traditional fee-for-service models to more outcomes-driven approaches, positioning it among key competitors in the market.
Evolent Health is a leader in value-based care enablement and population health management, competing with major players like Optum and Cerner. Its established relationships with large health systems and provider groups enhance its market presence and customer loyalty.
The company faces challenges including rising oncology costs, projected at a 12% increase for 2025, and potential impacts from Medicaid redeterminations. Implementation costs for automation and AI are also a factor, with a $10 million adjusted EBITDA drag anticipated in 2025.
In Q2 2025, Evolent Health reported a net loss of $19.9 million, marking its tenth consecutive quarterly loss. Total debt rose to $820.6 million, with a Net Debt to LTM Adjusted EBITDA ratio of 5.3x in Q2 2025, indicating increased leverage.
Evolent Health maintains a 2025 revenue outlook of $2.06 billion to $2.11 billion and adjusted EBITDA of $135 million to $165 million. Strategic focus includes innovation, data analytics, and enhancing its Identifi® platform and oncology solutions.
The company is targeting 20% annual EBITDA growth through organic expansion and AI-driven efficiencies, while prioritizing cash generation and debt reduction. A robust pipeline for new Performance Suite contracts, the largest in its history, suggests continued demand for its value-based care solutions.
Evolent Health's future growth is underpinned by its commitment to innovation and expanding its value-based care offerings. The company's strategic investments aim to drive margin improvements and revenue generation.
- Focus on AI-driven margin improvements for 20% annual EBITDA growth.
- Expansion of its Identifi® platform and oncology condition management.
- Leveraging data and analytics to enhance Evolent Health solutions.
- Capitalizing on a strong pipeline for new Performance Suite contracts.
- Prioritizing cash generation and debt paydown to strengthen financial health.
Evolent Health Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked

- What is Brief History of Evolent Health Company?
- What is Competitive Landscape of Evolent Health Company?
- What is Growth Strategy and Future Prospects of Evolent Health Company?
- What is Sales and Marketing Strategy of Evolent Health Company?
- What are Mission Vision & Core Values of Evolent Health Company?
- Who Owns Evolent Health Company?
- What is Customer Demographics and Target Market of Evolent Health Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.